compared to sera from mammals of the same species not having the cancer. [0144] Thus, the invention provides a diagnostic method useful during diagnosis of an immune system disorder, including cancers of the immune system, which involves measuring the expression level of the genes encoding the FcR-I, FcR-II, FcR-III, FcR-IV, or FcR-V protein in immune system tissue or other cells or body fluid fr